Thursday, July 30, 2015
Exclusive: GSK faces new corruption allegations, this time in Romania
LONDON (Reuters) - Drugmaker GlaxoSmithKline, which was fined a record 3 billion yuan ($483 million) for corruption in China last year and is examining possible staff misconduct elsewhere, faces new allegations of bribery in Romania.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment